Rezultati - Lee, Fa-Chyi
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers od Bauman, Julie, Shaheen, Monte, Verschraegen, Claire F., Belinsky, Steven A., Houman Fekrazad, M., Lee, Fa-Chyi, Rabinowitz, Ian, Ravindranathan, Meera, Jones, Dennie V.
Izdano 2014Text -
5
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer od Parikh, Aparna R., Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P., Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef
Izdano 2019Text -
6
INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial od Patt, Yehuda Z., Murad, Waheed, Fekrazad, Mohammed H., Baron, Ari D., Bansal, Pranshu, Boumber, Yanis, Steinberg, Kim, Lee, Sang‐Joon, Bedrick, Ed, Du, Ruofei, Lee, Fa Chyi
Izdano 2017Text -
7
A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors od Sweeney, Christopher J., Chiorean, E. Gabriela, Verschraegen, Claire F., Lee, Fa Chyi, Jones, Suzanne, Royce, Melanie, Tye, Lesley, Liau, Katherine F., Bello, Akintunde, Chao, Richard, Burris, Howard A.
Izdano 2010Text -
8
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer od Araujo‐Mino, Emilio P., Patt, Yehuda Z., Murray‐Krezan, Cristina, Hanson, Joshua A., Bansal, Pranshu, Liem, Ben J., Rajput, Ashwani, Fekrazad, M. Houman, Heywood, Glenory, Lee, Fa Chyi
Izdano 2017Text -
9
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer od Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Izdano 2013Text -
10
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer od Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Izdano 2021Text -
11
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre,... od Lu, Zhihao, Wang, Junye, Shu, Yongqian, Liu, Lianke, Kong, Li, Yang, Lei, Wang, Buhai, Sun, Guogui, Ji, Yinghua, Cao, Guochun, Liu, Hu, Cui, Tongjian, Li, Na, Qiu, Wensheng, Li, Gaofeng, Hou, Xinfang, Luo, Hui, Xue, Liying, Zhang, Yanqiao, Yue, Wenbin, Liu, Zheng, Wang, Xiuwen, Gao, Shegan, Pan, Yueyin, Galais, Marie-Pierre, Zaanan, Aziz, Ma, Zhuo, Li, Haoyu, Wang, Yan, Shen, Lin, Pan, Zhanyu, Zhang, Shuqun, Lin, Gen, Xie, Yanru, Li, Tao, Ren, Tiejun, Li, Weidong, Gu, Kangsheng, Wang, Shoufeng, He, Wei, Xia, Bing, Fan, Yun, Liang, Jun, Zhao, Kuaile, Pan, Hongming, Xu, Nong, Cheng, Ying, Gao, Quanli, Sun, Ping, Zang, Aimin, Zheng, Anping, Luo, Zhiguo, Liu, Tianshu, Ding, Shubo, Xu, Tianwen, Li, Wei, Liu, Fang, Cang, Shundong, Wang, Junsheng, Lin, Xiaoyan, Jiang, Da, Mao, Rui, Ma, Dong, Liu, Yunpeng, Tao, Min, Tang, Yong, Chen, Xi, Chen, Ping, Feng, Guosheng, Yang, Zhenzhou, Zhang, Guifang, Zhang, Xuebang, Huang, Yong, Lee, Fa-Chyi, Dean, Andrew, El Hajbi, Farid, Ghiringhelli, François, Borg, Christophe, Tougeron, David, Dahan, Laetitia, Pernot, Simon, Rivera, Fernando, Pazo Cid, Roberto Antonio, Vazquez Rivera, Maria Francisca
Izdano 2022Text